| Chairman |
|
Wu Yusheng |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman & Chief Executive Officer: Wu Yusheng
Executive Director: Jiang Mingyu
Non-executive Director: Li Jun, Gu Hong Eric, Meng Xiaoying, He Chao
Independent Non-executive Director: Zhang Senquan(Formerly known as Zhang Min), Leng Yuting, Xu Wenqing, Shen Xiuhua.
|
| Principle Business |
|
The Group is primarily engaged in the research, development and commercialisation of pharmaceutical products. |
| Related Indexes | | Hang Seng Composite SmallCap Index | Hang Seng Composite Index | | Hang Seng Healthcare Index | Hang Seng Healthcare Industry Index |
|
| Major Shareholders |
| Wu Yusheng & ASSO | 85,312,500 | NON-H SHS | 23.01% | 47.86% | 2024/08/20 | | Wu Yusheng & ASSO | 45,937,500 | H Sh | 12.39% | 23.85% | 2024/08/20 | | Jiangsu Addor Equity Investment Fund Management Co.,Ltd. | 20,400,000 | H Sh | - | 5.57% | 2025/02/18 | | Changxing Xingchang Industrial Investment Partnership (Limited Partnership) | 17,000,000 | H Sh | 4.58% | 8.83% | 2024/08/20 |
|
|
|
|
|